Skip to main content
Premium Trial:

Request an Annual Quote

Dicerna Pharmaceuticals Raises Additional $4M in Series B, Bringing Total to $29M

Premium

Dicerna Pharmaceuticals said this week that it has raised an additional $4 million in a second closing of Series B equity financing, bringing the total raised in this round to $29 million.

The company raised $25 million in the Series B in August (GSN 8/12/2010).

SR One, the venture capital arm of GlaxoSmithKline, participated in the financing as a new investor, joining existing investors Oxford Bioscience Partners, Skyline Ventures, Abingworth, and Domain Associates.

In conjunction with the investment, Brian Gallagher, a partner at SR One, will become an observer on Dicerna's board of directors.

Doug Fambrough, CEO of Dicerna, said in a statement that the company re-opened the Series B round "due to significant additional interest from the investment community in our unique Dicer Substrate Technology platform and next generation approach to developing RNAi therapeutics."

Dicerna said it plans to use the proceeds from the financing to further develop its lead in-house program in oncology and to improve its delivery technologies.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.